ApplicationIntermediate
Which drugs are indicated for the treatment of chronic obstructive pulmonary disease (COPD) according to the recent FDA drug approvals chapter?
Drugs indicated for the treatment of chronic obstructive pulmonary disease (COPD) include aclidinium, aclidinium/formoterol, albuterol, arformoterol, fluticasone, fluticasone/salmeterol, formoterol, hydrocortisone, indacaterol, ipratropium, revefenacin, roflumilast, salmeterol, and tiotropium.
Key points
- Aclidinium and aclidinium/formoterol are used for COPD.
- Albuterol and arformoterol are bronchodilators indicated for COPD.
- Fluticasone and fluticasone/salmeterol are corticosteroids for COPD management.
- Formoterol and indacaterol are long-acting bronchodilators for COPD.
- Ipratropium is an anticholinergic used in COPD treatment.
- Roflumilast is a phosphodiesterase-4 inhibitor for COPD.
- Tiotropium is a long-acting anticholinergic indicated for COPD.
Source:Mosbys 2021 Nursing Drug Reference by Linda Skidmore-Roth· Recent FDA Drug Approvals· p. 1391–1405
Related questions
Mosbys 2021 Nursing Drug Reference by Linda Skidmore-Roth
Unknown
THIRTY-FOURTH EDITION · Elsevier Inc.